Showing results (51-60 of 119) with videos related to
Sort By:
Pageof 12
European Journal of Clinical Pharmacology|November 9, 2001
Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypesS Hägg, O Spigset, H A Lakso, et al.Journal of Clinical Psychopharmacology|July 31, 2001
Myocarditis related to clozapine treatmentS Hägg, O Spigset, A Bate, et al.British Journal of Clinical Pharmacology|March 28, 1998
Non-linear fluvoxamine dispositionO Spigset, K Granberg, S Hägg, et al.European Journal of Clinical Pharmacology|August 24, 1999
Fluvoxamine is a potent inhibitor of tacrine metabolism in vivoJ T Larsen, L L Hansen, O Spigset, et al.European Journal of Clinical Pharmacology|January 1, 1997
Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphismsO Spigset, K Granberg, S Hägg, et al.Biological Psychiatry|March 11, 1999
Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapyK Smedh, O Spigset, P Allard, et al.Therapeutic Drug Monitoring|January 8, 1998
Urinary excretion of codeine, ethylmorphine, and their metabolites: relation to the CYP2D6 activityK Hedenmalm, M Sundgren, K Granberg, et al.Neuropsychobiology|November 24, 1999
Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adultsJ Sigurdh, O Spigset, P Allard, et al.Maturitas|January 13, 2006
Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesteroneL Andréen, O Spigset, A Andersson, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 8, 2018
Enantiomeric separation and quantification of R/S-amphetamine in urine by ultra-high performance supercritical fluid chromatography tandem mass spectrometryS Hegstad, H Havnen, A Helland, et al.Pageof 12